YZC-97571-27372
4 vaccinations
10 coded responses
54 check-ins
10 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 070 / NJ
- Registered
- 2021-03-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-18
Registered in v-safe
-
2021-03-18
Dose 1 — Moderna
- 2021-03-18
- 2021-03-19
- 2021-03-20
- 2021-03-21
- 2021-03-22
-
2021-03-23
Survey response — days 1–6 daily, dose 1MedDRA: Lymph node pain — Feeling: GoodFree text: a lymph node located in left axillary region is slightly tenderMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-24
Survey response — days 1–6 daily, dose 1MedDRA: Lymph node pain — Feeling: GoodFree text: 2nd day of a tender lymph node in left axillary regionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-25
Survey response — day 7, dose 1MedDRA: Lymph node pain — Feeling: Good · Site: ItchingFree text: 3rd day of tenderness in a lymph node in left axilla regioMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-01
- 2021-04-08
-
2021-04-15
Dose 2 — Moderna
- 2021-04-15
-
2021-04-16
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness, Itching · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness, Itching · Fatigue or tirednessAdult check-in
-
2021-04-19
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness, Itching · Fatigue or tirednessAdult check-in
- 2021-04-21
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-05-13
- 2021-05-20
- 2021-05-27
- 2021-07-15
- 2021-10-14
-
2021-12-07
Dose 3 — Moderna
- 2021-12-07
-
2021-12-08
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain, Swelling · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-09
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenitis — Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessFree text: axillary inflammation of lymph nodes w/same arm as injection siteMedDRA releases: 2024-11 · check-in free text available
-
2021-12-10
Survey response — days 1–6 daily, dose 3MedDRA: Injection site discomfort, Lymphadenitis — Feeling: Good · Site: SwellingFree text: mild discomfort at injection site; axillary lymph nodes are inflamed at same limb at injection siteMedDRA releases: 2024-11 · check-in free text available
-
2021-12-11
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenitis — Feeling: Good · Site: SwellingFree text: residual lymph node inflammation in axillary region in limb of injection siteMedDRA releases: 2024-11 · check-in free text available
- 2021-12-12
- 2021-12-13
- 2021-12-14
- 2021-12-21
- 2021-12-28
- 2022-01-04
- 2022-01-11
- 2022-01-18
- 2022-03-08
- 2022-06-07
-
2022-10-24
Dose 4 — Moderna
-
2022-10-24
Survey response — day 0, dose 4MedDRA: No adverse event — Feeling: GoodFree text: not at this timeMedDRA releases: 2024-11 · check-in free text available
-
2022-10-25
Survey response — days 1–6 daily, dose 4MedDRA: Lymph node pain — Feeling: Fair · Site: Swelling, Itching · Fatigue or tirednessFree text: axillary lymph nodes are a bit tenderMedDRA releases: 2024-11 · check-in free text available
-
2022-10-26
Survey response — days 1–6 daily, dose 4MedDRA: Injection site pain, Lymph node pain — Feeling: Fair · Site: Itching · Fatigue or tirednessFree text: slight tenderness @ injection site, but not swollen or red; slight tenderness in axillary lymph nodesMedDRA releases: 2024-11 · check-in free text available
-
2022-10-27
Survey response — days 1–6 daily, dose 4MedDRA: Lymph node pain — Feeling: GoodFree text: axillary lymph nodes slightly tender but not uncomfortableMedDRA releases: 2024-11 · check-in free text available
- 2022-10-28
- 2022-10-29
- 2022-10-30
- 2022-10-31
- 2022-11-07
- 2022-11-14
- 2022-11-21
- 2022-11-28
- 2022-12-06
- 2023-01-23
- 2023-04-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-18 | Moderna | |
| 2 | 2021-04-15 | Moderna | |
| 3 | 2021-12-07 | Moderna | No |
| 4 | 2022-10-24 | Moderna | No |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): a lymph node located in left axillary region is slightly tender
Systemic reaction (other): 2nd day of a tender lymph node in left axillary region
Release 6 — day 7, dose 1
Systemic reaction (other): 3rd day of tenderness in a lymph node in left axilla regio
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): axillary inflammation of lymph nodes w/same arm as injection site
Systemic reaction (other): mild discomfort at injection site; axillary lymph nodes are inflamed at same limb at injection site
Systemic reaction (other): residual lymph node inflammation in axillary region in limb of injection site
Release 12 — day 0, dose 4
Systemic reaction (other): not at this time
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): axillary lymph nodes are a bit tender
Systemic reaction (other): slight tenderness @ injection site, but not swollen or red; slight tenderness in axillary lymph nodes
Systemic reaction (other): axillary lymph nodes slightly tender but not uncomfortable
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Injection site discomfort | · | · | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenitis | · | · | ✓ |
| SRO | No adverse event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release